Dumalan, Sapphira Kate S.
HRN: 21-56-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
CEFUROXIME 1.5GM (VIAL)
08/23/2022
08/30/2022
IV
500mg
Q8
Uti With Mod Dhn
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes